SHS, established in 1993, is a German private equity firm headquartered in Tuebingen. It specializes in growth capital investments, focusing on the healthcare sector, including life sciences, medical technology, diagnostics, and biotechnology. The company manages funds such as SHS I and SHS V, targeting expansion-stage companies in Europe, with a typical investment size of up to EUR 30 million per company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.